Αρχική World News Groundbreaking Physicist Uses Laser Technology To Kill Cancer Cells Without Any Side...

Groundbreaking Physicist Uses Laser Technology To Kill Cancer Cells Without Any Side Effects

Dr. Hadiyah-Nicole Green has developed a successful method of killing cancer cells by using nanotechnology and lasers. After the aunt who raised her died from cancer, Green was inspired to develop a better treatment option.Green is only the 76th African American woman to receive a PhD in physics from an American university, according to the American Women In Physics website. She attended Alabama A&M University for her undergrad, and during the summer she interned at NASA, where she helped calibrate lasers for the International Space Station.She initially planned on furthering her work in physics. However, cancer stole two of her loved ones from her, and it changed the course of her life not only personally, but professionally.Photo: Facebook/Dr. Hadiyah-Nicole GreenGreen and her siblings were raised by their aunt and uncle, Ora Lee and General Lee Smith, after their mom and grandparents passed away. She was very close to her aunt.“She always made sure everyone was taken care of and treated every one from all walks of life with dignity and respect,” Green wrote on Facebook.Photo: Facebook/Dr. Hadiyah-Nicole GreenShortly after Green graduated from A&M, her aunt was diagnosed with female reproductive cancer. She decided to forgo treatment.“She said that she would rather die than experience the side effects of chemotherapy or radiation,” Green said. “I was her primary caregiver the last three months of her life, and I watched her go from this powerful matriarch in our family to being someone who couldn’t walk, speak, or stand on her own.”Three months after her aunt died, her uncle was diagnosed with esophageal cancer. Then he was diagnosed with prostate cancer. It wasn’t the cancer itself but the long-term side effects of his treatment that led to his death years later.Photo: Facebook/Dr. Hadiyah-Nicole GreenGreen went on to earn a Ph.D. in physics from the University of Alabama at Birmingham (UAB). While there, she used her vast experience in nanotechnology, immunotherapy, and precision medicines to create effective cancer treatment using lasers and nanoparticles. It’s unlike any traditional treatment, and results in no side effects.As a graduate student, Green injected gold particles into tumors and targeted them with a laser. Once the nanoparticles were hit, they vibrated and began to heat up. The heat eventually destroyed the tumor completely.Photo: Facebook/Ora Lee Smith Cancer Research FoundationUsing this Laser-Activated NanoTherapy (LANT) in only one 10-minute treatment, Green eliminated cancer in mice within 15 days.The laser targets only cancerous cells, leaving healthy ones unscathed and negating the need for additional treatment like chemo, surgery, or radiation. She also discovered that nanoparticles could be attached to tumor-specific antibodies, furthering its effectiveness. It can be used on multiple types of solid tumors, including breast, prostate, skin, colorectal, and brain cancers, and even ones previously considered inoperable or chemo-resistant.Photo: Facebook/Dr. Hadiyah-Nicole GreenCurrently, Green is an Assistant Professor at Morehouse School of Medicine in the Department of Surgery. She also created an organization in honor of her aunt called the Ora Lee Smith Cancer Research Foundation, where she is able to continue her research and further her mission of making cancer treatment accessible, affordable, and effective.“My goal is to change the way cancer is treated,” Green said.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ACHIEVE-2 Results of Oxaliplatin-Based Adjuvant Chemotherapy in Asian Patients with High-Risk Stage II Colon Cancer

The Asian researchers reported on 25 October 2020 in the Annals of Oncology that 3-month of combination therapy for adjuvant treatment of high-risk stage...

GreaterGood’s Mask Donations Are Helping LA Family Housing Keep Homeless People Safe

Due to the COVID-19 pandemic, people everywhere are uncertain about the future of their health, safety, and economic security. Homeless people and those who...

How I Found a Meaningful Career After Cancer

Jacky Costello is the founder and owner of a house cleaning company serving the greater Tampa Bay area in Florida. Through her company's partnership with...

Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age

October 26, 2020, by NCI Staff Radiopharmaceuticals consist of a radioactive molecule, a targeting molecule, and a linker that joins the two. Credit: National Cancer Institute The...

FDA Grants Regular Approval to Venetoclax in Combination for Untreated Acute Myeloid Leukaemia

On 16 October 2020, the US Food and Drug Administration (FDA) granted regular approval to venetoclax (VENCLEXTA ®, AbbVie Inc. and Genentech Inc.) in...

EMA Recommends Granting a Marketing Authorisation for Lenalidomide Mylan

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...